Soft Landing Labs, LTD Receives Going Public Approval
03/23/2014

Soft Landing Labs, LTD (OTCQB: SLNZ), announced its common stock is approved for quotation on the OTC Markets' OTC Pink Sheets marketplace under the ticker symbol "SLNZ" and its shares are eligible for electronic trading through Depository Trust Company ("DTC").

Online PR News – 23-March-2014 – Key Largo – Soft Landing Labs, LTD (OTCQB: SLNZ), announced its common stock is approved for quotation on the OTC Markets' OTC Pink Sheets marketplace under the ticker symbol "SLNZ" and its shares are eligible for electronic trading through Depository Trust Company ("DTC").Shareholders of SLNZ are able to view the real-time Level II stock quotes for the Company's common stock at http://www.otcmarkets.com/stock/SLNZ/quoteDr. Abdel Fahmy, Chief Executive Officer of SLNZ stated, "We are very pleased to have completed our going public transaction by being quoted on the OTCMarkets OTC Pink Sheets as the first step to creating liquidity, particularly for our current and future shareholders."About Soft Landing Labs, LTDSLNZ was founded in 2009, to provide specialized laboratory testing focused on small molecules and toxicology including drug testing using highly sensitive technology. For the nine month period ending September 30, 2013, SLNZ's revenues were $2,219,751Company Contact: Soft Landing Labs747 Church Rd Ste F4Elmhurst, IL 60126 Tel: 630-758-0030 Fax: 630-758-0040Legal Contact:Hamilton & Associates Securities LawyersBrenda Hamilton, Securities Attorney101 Plaza Real South, Suite 202 NBoca Raton, Florida 33432Telephone: (561) 416-8956Facsimile: (561) 416-2855www.SecuritiesLawyer101.comSPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS: This press release includes various "forward-looking statements" which represent the Company's expectations or beliefs concerning future events. Statements containing expressions such as "believes," "anticipates," "intends," or "expects," used in the Company's press releases and in Disclosure Statements and Reports filed through the OTC Disclosure and News Service are intended to identify forward-looking statements. All forward-looking statements involve risks and uncertainties. Although the Company believes its expectations are based upon reasonable assumptions within the bounds of its knowledge of its business and operations, there can be no assurances that actual results will not differ materially from expected results. The Company cautions that these and similar statements included in this report are further qualified by important factors that could cause actual results to differ materially from those in the forward-looking statements. Readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date thereof. The Company undertakes no obligation to publicly release any revisions to such forward-looking statements to reflect events or circumstances after the date hereof.